Syk kinase inhibitor R-935788
Term · Oncology and biomedicine · MLC-T-ONC-008433
A drug used to treat thrombocytopenia (a low blood platelet count) in adults with chronic immune thrombocytopenia (ITP) that did not get better with other treatment. ITP is a condition in which platelets are destroyed by the immune system. Syk kinase inhibitor R-935788 is also being studied in the treatment of other conditions and types of cancer. It blocks an enzyme called Syk, which may help keep the immune system from destroying platelets. Syk kinase inhibitor R-935788 is a type of tyrosine kinase inhibitor. Also called fostamatinib disodium, R788 sodium, and Tavalisse.
| Identifier | MLC-T-ONC-008433 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | fostamatinib disodium; R788 sodium; Tavalisse |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-008433",
"term": "Syk kinase inhibitor R-935788",
"field": "Oncology and biomedicine",
"definition": "A drug used to treat thrombocytopenia (a low blood platelet count) in adults with chronic immune thrombocytopenia (ITP) that did not get better with other treatment. ITP is a condition in which platelets are destroyed by the immune system. Syk kinase inhibitor R-935788 is also being studied in the treatment of other conditions and types of cancer. It blocks an enzyme called Syk, which may help keep the immune system from destroying platelets. Syk kinase inhibitor R-935788 is a type of tyrosine kinase inhibitor. Also called fostamatinib disodium, R788 sodium, and Tavalisse.",
"synonyms": [
"fostamatinib disodium",
"R788 sodium",
"Tavalisse"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/syk-kinase-inhibitor-r-935788/"
}
Record 15,854 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.